Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
86.50
+0.69 (0.80%)
At close: Jul 19, 2024, 4:00 PM
86.81
+0.31 (0.36%)
Pre-market: Jul 22, 2024, 4:30 AM EDT
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for EW stock have an average target of 96.32, with a low estimate of 57 and a high estimate of 110. The average target predicts an increase of 11.35% from the current stock price of 86.50.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EW stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 7 | 7 | 7 |
Buy | 8 | 8 | 8 | 7 | 7 | 7 |
Hold | 6 | 6 | 6 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 18 | 19 | 19 | 20 | 20 | 20 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +27.17% | Jul 16, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $105 → $106 | Strong Buy | Maintains | $105 → $106 | +22.54% | Jul 10, 2024 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $89 → $91 | Hold | Maintains | $89 → $91 | +5.20% | Jul 2, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $107 | Strong Buy | Initiates | $107 | +23.70% | May 30, 2024 |
Citigroup | Citigroup | Hold → Strong Buy Upgrades $98 → $105 | Hold → Strong Buy | Upgrades | $98 → $105 | +21.39% | May 22, 2024 |
Financial Forecast
Revenue This Year
6.76B
from 6.00B
Increased by 12.56%
Revenue Next Year
7.42B
from 6.76B
Increased by 9.78%
EPS This Year
2.85
from 2.30
Increased by 23.78%
EPS Next Year
3.21
from 2.85
Increased by 12.88%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.0B | 7.7B | 8.6B | 9.3B | 10.1B |
Avg | 6.8B | 7.4B | 8.1B | 8.9B | 9.6B |
Low | 6.3B | 6.8B | 7.4B | 8.2B | 8.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.8% | 14.4% | 15.7% | 14.9% | 14.0% |
Avg | 12.6% | 9.8% | 9.4% | 9.4% | 8.5% |
Low | 5.7% | 1.0% | -0.4% | 0.4% | -0.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.94 | 3.60 | 3.91 | 4.34 | 4.80 |
Avg | 2.85 | 3.21 | 3.56 | 4.01 | 4.38 |
Low | 2.61 | 2.78 | 3.04 | 3.57 | 3.88 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.8% | 26.5% | 21.7% | 21.9% | 19.6% |
Avg | 23.8% | 12.9% | 10.9% | 12.6% | 9.1% |
Low | 13.3% | -2.2% | -5.5% | 0.1% | -3.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.